Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Class A
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 29, 2022   106,151,000      
Beginning balance at Dec. 29, 2022 $ 1,657,176 $ 106 $ 482,312 $ 4,337 $ 1,170,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 27,240   27,240    
Exercise of stock options (in shares)   491,000      
Exercise of stock options $ 10,960 $ 1 10,959    
Issuance of common stock upon vesting of restricted stock units (in shares)   151,000      
Shares issued under employee stock purchase plan (in shares) 83,686 84,000      
Shares issued under employee stock purchase plan $ 5,159   5,159    
Common stock redeemed for tax liability (in shares)   (139,000)      
Common stock redeemed for tax liability (12,610)   (12,610)    
Other comprehensive gain (loss), net of tax (2,915)     (2,915)  
Net income 245,980       245,980
Ending balance (in shares) at Dec. 28, 2023   106,738,000      
Ending balance at Dec. 28, 2023 1,930,990 $ 107 513,060 1,422 1,416,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 33,695   33,695    
Exercise of stock options (in shares)   457,000      
Exercise of stock options $ 10,115   10,115    
Issuance of common stock upon vesting of restricted stock units (in shares)   226,000      
Shares issued under employee stock purchase plan (in shares) 58,665 59,000      
Shares issued under employee stock purchase plan $ 5,459   5,459    
Common stock redeemed for tax liability (in shares)   (123,000)      
Common stock redeemed for tax liability (14,511)   (14,511)    
Other comprehensive gain (loss), net of tax (1,462)     (1,462)  
Net income $ 205,872       205,872
Ending balance (in shares) at Dec. 26, 2024 107,356,999 107,357,000      
Ending balance at Dec. 26, 2024 $ 2,170,158 $ 107 547,818 (40) 1,622,273
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense $ 29,505   29,505    
Exercise of stock options (in shares) 153,456 153,000      
Exercise of stock options $ 3,453   3,453    
Issuance of common stock upon vesting of restricted stock units (in shares)   280,000      
Issuance of common stock upon vesting of restricted stock units $ 0 $ 1 (1)    
Shares issued under employee stock purchase plan (in shares) 78,187 78,000      
Shares issued under employee stock purchase plan $ 5,970   5,970    
Common stock redeemed for tax liability (in shares)   (94,000)      
Common stock redeemed for tax liability (8,959)   (8,959)    
Other comprehensive gain (loss), net of tax 62     62  
Net income $ 208,647       208,647
Ending balance (in shares) at Dec. 25, 2025 107,774,329 107,774,000      
Ending balance at Dec. 25, 2025 $ 2,408,836 $ 108 $ 577,786 $ 22 $ 1,830,920